Navigation Links
ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union
Date:6/24/2011

thorization Applications (MAAs) for medicines for human use. Their positive opinion forms the scientific basis for the European Commission to issue a binding decision for an MAA or a PUMA, a centralized marketing authorization which is valid throughout all the Member States of the European Union (EU) as well as in the European Economic Area (EEA), namely Norway, Iceland and Liechtenstein. The anticipated timeframe for the European Commission decision is by the fourth quarter of 2011.  A summary of the CHMP opinion will be available here: http://tinyurl.com/2am4ubc.  Please select "B" to access the Buccolam summary opinion.  

"This positive CHMP opinion - the first for a product seeking centralized authorization through a PUMA - is a great step towards the European marketing authorization for Buccolam, a product that addresses significant unmet need for families and caregivers – namely the quick and effective termination of prolonged, acute convulsive seizures in children and adolescents," commented Thierry Darcis, M.D., ViroPharma's vice president, general manager, Europe.  "We will work closely with physicians across Europe on improving the seizure treatment paradigm, and bringing this much-needed emergency medication to market as soon as possible this year."

A Pediatric Use Marketing Authorization (PUMA) is a new type of centralized marketing authorization procedure for medicines that are developed specifically for children and may already be authorized for other indications or routes of administration in adults but are not patented. These medicines benefit from 10 years of market protection as an incentive.  In August 2010, the EMA's Pediatric Committee (PDCO) confirmed that the required Pediatric Investigation Plan (PIP) for Buccolam had been fully completed.  

About Buccolam® (Midazolam, Oromucosal Solution)

Buccolam is oral midazolam prov
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
2. ViroPharma to Participate in the Jefferies 2011 Global Healthcare Conference
3. ViroPharma Launches Swell, an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema
4. ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
5. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
6. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
7. ViroPharma to Participate In Three May Healthcare Investor Conferences
8. ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011
9. ViroPharma Initiates Phase 2 Study of C1 Esterase Inhibitor [Human] for Treatment of Antibody-Mediated Rejection (AMR)
10. ViroPharma Launches HAE and Me, A New Online Community to Unite People Living With Hereditary Angioedema
11. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... STAAR Surgical Company (NASDAQ: STAA ), ... and delivery systems for the eye, today announced that ... Roush , CPA to the Company,s Board. This appointment ... to seven.Mr. Roush brings an important combination of financial ... 39 year tenure as a Partner at PricewaterhouseCoopers, prior ...
(Date:4/21/2015)... and CAMBRIDGE, Mass. , April ... Tokyo : 4503) and Potenza Therapeutics, Inc., ... programs, today announced an exclusive research and development ... advance a portfolio consisting of programs with novel ... signals and regulatory T cells. The agreement includes ...
(Date:4/21/2015)... Calif. and TOKYO , ... international life science partnering conferences, has just announced ... for the innovative medical technology industry. The event, held ... be the first dedicated international medtech partnering conference in ... will provide insights into new developments in the rapidly ...
Breaking Medicine Technology:J. Steven Roush, CPA Appointed to STAAR Surgical Board of Directors 2J. Steven Roush, CPA Appointed to STAAR Surgical Board of Directors 3Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics 2Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics 3Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 2Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 3Inaugural Medtech Partnering Forum to feature leading global medtech decision makers this May 28-29, 2015 in Tokyo, Japan 4
... CHICAGO, June 04, 2007 /PRNewswire/ -- GlaxoSmithKline ... of pazopanib in,advanced or metastatic renal cell ... (STS). These trials were presented at the,43rd ... Clinical Oncology,(ASCO) in Chicago. The results observed ...
... /PRNewswire/ -- (SEND2PRESS,NEWSWIRE) -- Epeius Biotechnologies Corporation today ... oncology and a,definitive benchmark in the emerging field ... its kind, Le Morte du Tumour --,published in ... Vol.30, pp. 1297-1307 -- documents the histologic,features of ...
Cached Medicine Technology:GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 3
(Date:4/21/2015)... 2015 Edward Avalos, USDA Under Secretary ... former Secretary of the California Department of Food and ... 2nd Annual GrowRIVERSIDE Conference: The Future of Local Food, ... of these nationally known experts intensifies an already strong ... and others slated to speak at the June 11-13 ...
(Date:4/21/2015)... 21, 2015 Respected academic institution selects ... , Visage Imaging Inc. (“Visage”), a wholly owned ... signed a seven-year contract with University of Florida Health ... The deal furthers the penetration of Visage ... key area of the North American enterprise imaging market. ...
(Date:4/21/2015)... Wojo Nutrition announces Abe’s Market ... healthiest, will carry Wojo Nutrition's lines of single serving ... they’ve launched a revolution in the vitamin industry that ... their multifaceted goals. Their line of single serving liquid ... been specially formulated to be as unique as the ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Now ... & Exhibition is set to unite over 3,000 ... mobile communities at the Suburban Collection Showplace on ... automakers including Volvo, Nissan, Ford, and Kia are ... how the connected car is reshaping automotive as ...
(Date:4/21/2015)... April 21, 2015 Carinsuranceshoppingsource.com has ... analyzing comprehensive auto insurance plans . , ... provides coverage for numerous situations. The coverage limit can ... Comprehensive auto insurance will protect a car against fire ... , Comparing quotes is no longer difficult and it ...
Breaking Medicine News(10 mins):Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 2Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 3Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4Health News:Wojo Nutrition Announces their Lines of Single Serving Liquid Vitamins will be Available for Purchase online at Abesmarket.com Beginning in May 2Health News:TU-Automotive Detroit 2015 Sample Attendee List Released 2Health News:TU-Automotive Detroit 2015 Sample Attendee List Released 3Health News:Comprehensive Auto Insurance Is An Important But Complex Policy 2
... Jan. 22 SeQual Technologies Inc., a medical ... for their reliability, quality, and revolutionary design and ... (AWR) from the U.S. Army,s Research, Development, and ... The certification indicates that the Eclipse(R) Oxygen Concentrator ...
... of its Board of Directors, held today, Wyeth (NYSE: ... Preferred Stock of the Company.A dividend of thirty cents ($.30) ... declared payable on March 2, 2009 to stockholders of record ... In addition, a dividend of fifty cents ($.50) per share ...
... Turner Construction Company, the nation,s largest builder of ... million construction project at Children,s Hospital Central California in ... 59,531 sq. ft. addition to and a 17,306 sq. ... the expansion of the emergency and trauma departments, four ...
... Petitions to Congressman Obey,s OfficeWASHINGTON, Jan. 22 ... a petition with 45,000 signatures to ... and his Wisconsin district, urging him to use ... Committee to ensure that taxpayers are not forced ...
... Hospitals with more expertise handling these attacks also ... News) -- Brain hemorrhage patients have better outcomes ... handle many brain attack emergencies, according to updated ... Subarachnoid hemorrhage (SAH) occurs when a blood vessel ...
... free or nearly free events offered this Saturday, January 24 ... history-making celebration where yogis, novices, couch potatoes and triathletes, young, ... body and spirit through the practice of yoga is this ... of karma yoga, or service to others, all Yoga Day ...
Cached Medicine News:Health News:SeQual Technologies is Awarded the U.S. Army Airworthiness Certification 2Health News:New Brain Hemorrhage Guidelines Stress Quick Action 2Health News:Yoga Day USA Changes Lives and Builds Community 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: